论文部分内容阅读
Pearl治疗有限公司宣布其富马酸福莫特罗(formoterol fumarate)氢氟烷定量气雾吸入剂(HAF-MDI)在治疗慢性阻塞性肺病Ⅱa期临床试验中扩支气管疗效明显,耐受性良好,安全性与阳性对照药相当。福莫特
Pearl Therapy Ltd. announced that its formoterol fumarate HAF-MDI has demonstrated a significant and well-tolerated bronchodilator in the treatment of stage Ⅱa chronic obstructive pulmonary disease , Safety and positive control drug equivalent. Formotte